Atrys Health, S.A. (FRA:A2T)

Market Cap	221.55M -19.8%
Revenue (ttm)	226.24M +7.2%
Net Income	-24.59M
EPS	-0.32
Shares Out	n/a
PE Ratio	n/a
Forward PE	32.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	2.640
Previous Close	2.850
Day's Range	2.640 - 2.850
52-Week Range	2.210 - 3.730
Beta	n/a
RSI	48.96
Earnings Date	Mar 28, 2026

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ...

• Industry: Medical Laboratories
• Founded: 2007
• Employees: 2,016
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A2T

Financial Performance

In 2024, Atrys Health's revenue was 218.10 million, an increase of 5.82% compared to the previous year's 206.10 million. Losses were -31.77 million, -30.30% less than in 2023.